Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
WBA logo WBA
Upturn stock ratingUpturn stock rating
WBA logo

Walgreens Boots Alliance Inc (WBA)

Upturn stock ratingUpturn stock rating
$11.98
Last Close (24-hour delay)
Profit since last BUY7.64%
upturn advisory
Consider higher Upturn Star rating
BUY since 74 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: WBA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

14 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $11.93

1 Year Target Price $11.93

Analysts Price Target For last 52 week
$11.93 Target price
52w Low $7.98
Current$11.98
52w High $13.25

Analysis of Past Performance

Type Stock
Historic Profit -41.55%
Avg. Invested days 24
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 10.37B USD
Price to earnings Ratio -
1Y Target Price 11.93
Price to earnings Ratio -
1Y Target Price 11.93
Volume (30-day avg) 14
Beta 0.77
52 Weeks Range 7.98 - 13.25
Updated Date 08/28/2025
52 Weeks Range 7.98 - 13.25
Updated Date 08/28/2025
Dividends yield (FY) 4.19%
Basic EPS (TTM) -7.29

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -4.07%
Operating Margin (TTM) 0.74%

Management Effectiveness

Return on Assets (TTM) 0.83%
Return on Equity (TTM) -69.58%

Valuation

Trailing PE -
Forward PE 7.7
Enterprise Value 38573416886
Price to Sales(TTM) 0.07
Enterprise Value 38573416886
Price to Sales(TTM) 0.07
Enterprise Value to Revenue 0.25
Enterprise Value to EBITDA -22.57
Shares Outstanding 865561024
Shares Floating 716009102
Shares Outstanding 865561024
Shares Floating 716009102
Percent Insiders 17.44
Percent Institutions 60.94

ai summary icon Upturn AI SWOT

Walgreens Boots Alliance Inc

stock logo

Company Overview

overview logo History and Background

Walgreens Boots Alliance Inc. (WBA) traces its roots back to 1901 when Charles Walgreen opened his first drugstore in Chicago. Over the decades, Walgreens expanded its retail footprint and diversified its offerings. In 2014, Walgreens merged with Alliance Boots, creating Walgreens Boots Alliance.

business area logo Core Business Areas

  • U.S. Retail Pharmacy: Includes Walgreens and Duane Reade pharmacies across the United States, offering prescription services, health and wellness products, beauty products, and photo services.
  • International: Encompasses Boots pharmacies and healthcare services primarily in the United Kingdom and Europe, as well as global wholesale and distribution.
  • U.S. Healthcare: Provides technology-enabled healthcare solutions through Shields Health Solutions, VillageMD, and CareCentrix

leadership logo Leadership and Structure

The CEO of Walgreens Boots Alliance is Tim Wentworth. The company operates with a hierarchical structure, dividing operations into the U.S. and International segments. The Board of Directors provides oversight and strategic guidance.

Top Products and Market Share

overview logo Key Offerings

  • Prescription Medications: Walgreens is a major distributor of prescription drugs. Competition comes from CVS (CVS), Rite Aid (RAD), and Amazon Pharmacy (AMZN). No specific market share available.
  • Health and Wellness Products: Includes over-the-counter medications, vitamins, and supplements. Competitors include Walmart (WMT), Target (TGT), and Amazon (AMZN). No specific market share available.
  • Beauty Products: Cosmetics, skincare, and hair care products. Competitors include Sephora, Ulta Beauty, and department stores. No specific market share available.

Market Dynamics

industry overview logo Industry Overview

The retail pharmacy industry is facing increasing competition from online retailers and evolving healthcare models. Consolidation and vertical integration are key trends. Aging populations, increasing chronic diseases, and greater access to healthcare all affect the industry.

Positioning

Walgreens Boots Alliance is a major player in the retail pharmacy and healthcare sector, with a strong brand recognition and extensive network of stores. They compete on convenience, brand loyalty, and an integrated pharmacy/retail model.

Total Addressable Market (TAM)

The U.S. pharmacy market is projected to reach hundreds of billions of dollars. WBA is strongly positioned but facing growing competition from both brick and mortar stores such as CVS and online stores such as Amazon.

Upturn SWOT Analysis

Strengths

  • Extensive Retail Footprint
  • Strong Brand Recognition
  • Established Pharmacy Network
  • Strategic Partnerships (e.g., VillageMD)

Weaknesses

  • High Debt Levels
  • Declining Retail Sales
  • Competitive Pressure
  • Integration Challenges (Acquisitions)

Opportunities

  • Expanding Healthcare Services
  • Growing Online Presence
  • Strategic Partnerships
  • Aging Population

Threats

  • Increased Competition
  • Changing Healthcare Regulations
  • Economic Downturn
  • Supply Chain Disruptions

Competitors and Market Share

competitor logo Key Competitors

  • CVS (CVS)
  • Rite Aid (RAD)
  • Amazon (AMZN)

Competitive Landscape

Walgreens faces intense competition from CVS, which has a similar retail pharmacy model. Amazon is a growing threat with its online pharmacy. Walgreens differentiates itself through its strong brand recognition and strategic partnerships.

Major Acquisitions

Shields Health Solutions

  • Year: 2021
  • Acquisition Price (USD millions): 1375
  • Strategic Rationale: Strengthens Walgreens' position in specialty pharmacy and expands its healthcare services capabilities.

Growth Trajectory and Initiatives

Historical Growth: Historical Growth information not available for public disclosure in this response.

Future Projections: Future Projections information not available for public disclosure in this response.

Recent Initiatives: Walgreens Boots Alliance has focused on expanding its healthcare services, including partnerships with VillageMD to open primary care clinics co-located with Walgreens stores. They have also invested in digital health solutions to improve patient engagement.

Summary

Walgreens Boots Alliance has an extensive retail footprint and a strong brand. It faces challenges including high debt and growing competition from online pharmacies. Expanding healthcare services represents a significant growth opportunity, but the company must adapt to evolving consumer preferences and regulatory changes. With a solid presence Walgreens Boots Alliance is still facing headwind issues such as debt and decline in retail sales.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings
  • Market Research Reports
  • Financial News Outlets

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Walgreens Boots Alliance Inc

Exchange NASDAQ
Headquaters Deerfield, IL, United States
IPO Launch date 1985-07-01
CEO & Director Mr. Timothy C. Wentworth
Sector Healthcare
Industry Pharmaceutical Retailers
Full time employees 193000
Full time employees 193000

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.